Cutaneous melanona in a multiethnic population is this a different disease?

Archives of Surgery

Volumn 139, Issue 9, 2004, Pages 968-973

  Hemmings, Daphne E ^a   Johnson, D Scott ^a   Tominaga, Gail T ^a   Wong, Jan H ^a,b   Leong, Stanley P L ^c   O'Connell, Theodore X ^c   Lee, Margarette ^c   Vetto, John T ^c   Pearl, Jeffrey M ^c   Johnson, Nathalie M ^c  

^a UNIVERSITY OF HAWAII   (United States)

^b UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; ASIAN; CANCER DIAGNOSIS; CANCER LOCALIZATION; CHINESE; EARLY DIAGNOSIS; ETHNIC GROUP; EUROPEAN AMERICAN; FEMALE; FILIPINO; GENDER; HISPANIC; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; SKIN COLOR; THICKNESS; TUMOR VOLUME; UNIVERSITY HOSPITAL; CHI SQUARE DISTRIBUTION; ETHNOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PHENOTYPE; PROPORTIONAL HAZARDS MODEL; SKIN TUMOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; PHENOTYPE; PROPORTIONAL HAZARDS MODELS; SKIN NEOPLASMS;

EID: 4444257431     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.139.9.968     Document Type: Article

References (32)

1. Dooley TP. Recent advances in cutaneous melanoma oncogenesis research. Oncol Res. 1994;6:1-9.
2. Koh H, Geller A, Miller D, Caruso A, Gage I, Lew RA. Who is being screened for melanoma/skin cancer? characteristics of persons screened in Massachusetts. J Am Acad Dermatol. 1991;24:271-277.
3. Rigel D, Carucci J. Malignant melanoma: prevention, early detection, and treatment in the 21st century. CA Cancer J Clin. 2000;50:215-236.
4. Cress RD, Holly EA. Incidence of cutaneous melanoma among non-Hispanic whites, Hispanics, Asians, and blacks: an analysis of California Cancer Registry Data, 1988-93. Cancer Causes Control. 1997;8:246-252.
5. Balch CM, Soong S-J, Bartolucci AA, et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg. 1996;224:255-266.
6. Morton DL, Duan-Ren W, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392-399.
7. Reintgen D, Cruse CW, Wells K, et al. The orderly progression of melanoma nodal metastases. Ann Surg. 1994;220:759-767.
8. Kirkwood J, Strawderman M, Ernstoff M, Smith TJ, Borden EC, Blum RH. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol. 1996;14:7-17.
9. O'Day S, Kim C, Reintgen D. Metastatic melanoma: chemotherapy to biochemotherapy. Cancer Control. 2002;9:31-38.
10. Kaplan E, Meier P. Nonparametric estimation from incomplete observation. J Am Statistics Assoc. 1958;53:457-481.
11. Bergfelt L, Newell B, Sider J, Kripke M. Incidence and anatomic distribution of cutaneous melanoma among United States Hispanics. J Surg Oncol. 1989;40: 222-226.
12. Kato T, Suetake T, Tabata N, Takahashi K, Tagami H. Epidemiology and prognosis of plantar melanoma in 62 Japanese patients over a 28-year period. Int J Dermatol. 1999;38:515-519.
13. Collins RJ. Melanoma in the Chinese of Hong Kong. Cancer. 1984;54:1482-1488.
14. Bellows CF, Belafsky P, Fortgang IS, Beech DJ. Melanoma in African-Americans: trends in biological behavior and clinical characteristics over two decades. J Surg Oncol. 2001;78:10-16.
15. Ishihara K, Saida T, Yamamoto A. Updated statistical data for malignant melanoma in Japan. Int J Clin Oncol. 2001;6:109-116.
16. Urist M, Balch C, Soong S, et al. Head and neck melanoma in 534 clinical stage I patients. Ann Surg. 1984;200:769-775.
17. Day CL Jr, Mihm MC Jr, Sober AJ, et al. Prognostic factors for melanoma patients with lesions 0.76-1.69 mm in thickness. Ann Surg. 1982;195:30-34.
18. Law M, Wong J. Evaluation of the prognostic significance of the site of origin of cutaneous melanoma. Am Surg. 1994;60:362-366.
19. Essner R, Wong J, Economou J, Morton D. Prognostic significance of melanoma arising in the scalp. Am J Surg. 1988;156:314-317.
20. Kuchelmeister C, Schaumburg-Lever G, Garbe C. Acral cutaneous melanoma in caucasians: clinical features, histopathology and prognosis in 112 patients. Br J Dermatol. 2000;143:275-280.
21. Talley L, Soong S, Harrison R, McCarthy WH, Urist MM, Balch CM. Clinical outcomes of localized melanoma of the foot: a case-control study. J Clin Epidemiol. 1998;51:853-857.
22. Wells K, Reintgen D, Cruse C. The current management and prognosis of acral lentiginous melanoma. Ann Plast Surg. 1992;28:100-103.
23. Balch C, Soong S, Gershenwald J, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system J Clin Oncol. 2001;19:3622-3634.
24. Fountain J, Bale S, Housman D, Dracopoll N. Genetics of melanoma. Cancer Surv. 1990;9:645-671.
25. Temoshok L, Diclemente R, Sweet D, Blois MS, Sagebiel RW. Factors related to patient delay in seeking medical attention for cutaneous malignant melanoma. Cancer. 1984;54:3048-3053.
26. Cassileth B, Temoshok L, Frederick B, et al. Patient and physician delay in melanoma diagnosis. J Am Acad Dermatol. 1988;18:591-598.
27. Brochez L, Verhaeghe E, Bleyen L, Naeyaert J. Diagnostic ability of general practitioners and dermatologists in discriminating pigmented skin lesions. J Am Acad Dermatol 2001;44:979-986.
28. Cassileth B, Clark WJ, Lusk E, Frederick BE, Thompson CJ, Walsh WP. How well do physicians recognize melanoma and other problem lesions? J Am Acad Dermatol. 1986;14:555-5601.
29. Franke W, Neuman N, Ruzicka T, Schulte K. Planta malignant melanoma: a challenge for early recognition. Melanoma Res. 2000;10:571-576.
30. Richard M, Grob J, Avril M, et al. Delays in diagnosis and melanoma prognosis, II: the role of the doctors. Int J Cancer. 2000;89:280-285.
31. Bennett D, Wasson D, MacArthur JD, McMillen MA. The effect of misdiagnosis and delay in diagnosis on clinical outcome in melanomas of the foot. J Am Coll Surg. 1994;179:279-284.
32. Kato T, Suetake T, Sugiyama Y, et al. Improvement in survival rate of patients with acral melanoma observed in the past 22 years in Sendai, Japan. Clin Exp Dermatol. 1993;18:107-110.